🇨🇦 Canadian Headquarters · GMP Manufacturing Network Across 5 Countries +1 (437) 595-0172  |  [email protected]
GMP Probiotic Supplement Manufacturing cleanroom facility by Q Nutritions
High speed capsule filling equipment for shelf stable probiotic manufacturing
Analytical QC laboratory verifying probiotic strain CFU and water activity
Health Canada Licensed · FDA Registered · ISO Class 7 Cleanroom

Probiotic Supplement Manufacturing Engineered for 24-Month CFU Stability

Conquer strain mortality and global compliance. Canadian GMP contract manufacturer specializing in low-humidity encapsulation, microencapsulation, spore-formers, and shelf-stable probiotic formulations shipped to 40+ countries.

Water Activity (aw) < 0.15
RH < 20% Cleanrooms
16S rRNA Strain Verification
0Years Experience
0Commercial SKUs
0Global Markets
0Brand Partners
0On-Time Delivery
0Global Facilities

Audit-Ready Probiotic Quality Baseline

🇨🇦 Health Canada Site Licence 🇺🇸 US FDA Registered ✅ cGMP Certified 🔬 NSF International 🌿 Non-GMO Project Verified ☪️ Halal Certified ✡️ Kosher Certified 🛡️ HACCP Compliant 📋 ISO 22000:2018
Low humidity probiotic manufacturing cleanroom in Mississauga Canada
cGMP & ISO 22000
aw < 0.15Strict Moisture Barrier Controls
Technical Mastery

Solving the Live-Cell Viability Bottleneck in Probiotic OEM/ODM

Probiotics are active, delicate biological organisms. Traditional contract supplement manufacturers frequently fail brand owners by treating sensitive freeze-dried strains like standard vitamin powders. Exposure to atmospheric moisture ($RH > 30\%$), heat during blending, or mechanical shear can destroy up to 80% of live Colony Forming Units (CFU) prior to bottle sealing.

At Q Nutritions, our Canadian contract manufacturing facility in Mississauga, Ontario, operates specialized low-humidity suites maintaining relative humidity below 20% and temperatures under 20°C. We implement bio-shielding matrix design, exact moisture-activity ($a_w$) targets, dynamic overage algorithms, and acid-resistant encapsulations so your label claim holds true through the entire 24-month shelf life.

  • RH < 20% packaging & blending environment
  • 16S rRNA genomic strain identification
  • DRcaps® gastric acid bypass technology
  • ISO 19344 Flow Cytometry cell counting
  • Health Canada NPN & US FDA regulatory assistance
  • Desiccated packaging & nitrogen-flushed sealing
End-to-End Capabilities

Full-Lifecycle Probiotic Contract Development & Manufacturing

Eliminate inter-vendor friction. We integrate custom strain selection, galenic formulation, stability testing, and regulatory export filing under one validated cGMP umbrella.

Custom Strain Blending

Engineered multi-strain matrices (Lactobacillus, Bifidobacterium, Bacillus spores) combined with prebiotics, enzymes, or targeted botanicals.

Learn about formulation →

Probiotic Contract Manufacturing

High-volume encapsulation, tablet compression, and powder blending inside humidity-monitored Cleanroom suites with zero cross-contamination.

Contract manufacturing →

Turnkey Private Label Solutions

Market-ready, clinically backed stock probiotic formulas for gut health, immunity, vaginitis, and mood, customized with your branding.

Explore private label →

Regulatory & NPN Licensing

In-house filing for Health Canada Natural Product Numbers (NPNs), US FDA structure/function claims, EU notifications, and GCC dossiers.

Regulatory compliance →

Desiccated Packaging Engineering

CSP Activ-Vial™ bottles, Alu-Alu cold-form blisters, and nitrogen-purged sachets engineered to block oxygen and moisture transmission.

Packaging options →

Qualified Strain Sourcing

Direct partnerships with top global strain banks providing clinical documentation, strain stability data, and IP protection.

Ingredient sourcing →

Microbial Analytical Testing

16S rRNA sequencing, MALDI-TOF mass spectrometry, Flow Cytometry (AFU/CFU), water activity assays, and 24-month stability chambers.

Quality testing →

Cold-Chain & Ambient Shipping

Temperature-monitored international logistics (FOB, CIF, DDP) supported by Free Sale Certificates and Certificate of Analysis (COA).

Global logistics →
Market Intelligence

Probiotic Manufacturing Trends: 2026–2030 Global Outlook

As global buyers pivot toward evidence-based microbiome solutions, AI search engines prioritize suppliers delivering actionable information gain. Here are the macro shifts shaping high-margin procurement.

1. Transition to AFU Flow Cytometry Global regulators and premium brands are shifting from traditional plate counts (CFU) to Flow Cytometry (ISO 19344) measuring Active Fluorescent Units (AFU) for pinpoint cell viability determination.
2. Organ-Specific Microbiome Axes Procurement focus is expanding rapidly beyond general gut health into clinically validated strains for the Gut-Brain (psychobiotics), Gut-Skin (dermatology), and Vaginal Microbiome axes.
3. Dominance of Soil Spore-Formers Bacillus coagulans, Bacillus subtilis, and Bacillus clausii are replacing sensitive lactic acid strains in functional foods and gummies due to natural endospore thermal resistance.
4. Heat-Treated Postbiotic Surge Inactivated microbial cells and metabolites eliminate cold-chain storage risks, allowing brands to launch ambient beverages, cosmetic topical creams, and stable pet supplements.
5. Smart Active-Barrier Packaging Transition from standard PET to CSP Activ-Polymer™ desiccant sleeves and Alu-Alu cold-form blisters that actively scavenge internal headspace moisture throughout shelf life.
6. Synbiotic & HMO Multi-Action Combining precision human milk oligosaccharides (2'-FL HMO) or xylo-oligosaccharides (XOS) with targeted live strains creates synergistic formulas with superior clinical outcome data.
Enterprise Strengths

Why International Brands Partner With Q Nutritions for Probiotic CDMO

Engineering precision verified through batch documentation, strict environmental parameters, and rigorous analytical release standards.

Canadian Health Baseline

Manufactured under Health Canada Natural Health Product (NHP) Site Licence guidelines—globally respected as one of the strictest quality standards.

Low-Humidity Processing

Dedicated Cleanrooms maintaining < 20% RH and controlled temperatures prevent premature moisture absorption and cell metabolic activation.

Kinetic Overage Modeling

Calculated dynamic overages based on real-time strain stability data rather than guessing, protecting profit margins while ensuring 100% claim compliance.

Strain-Specific DNA Assays

In-house 16S rRNA gene sequencing and PCR verification ensure zero strain substitution or strain drift across production lots.

Advanced Microencapsulation

Lipid coated and plant-protein encapsulated raw strain options for high resistance against stomach acids and bile salts.

Turnkey Dossier Support

NPN registration, FDA 21 CFR Part 111 panel review, EU food supplement notifications, Free Sale Certificates, and full CoA execution.

Flexible Global Logistics

Integrated cold-chain or climate-monitored air/sea freight serving distributors across North America, Europe, Asia, LATAM, and Middle East.

Dedicated Account Director

A single point of technical contact coordinating R&D formulation, pilot runs, analytical release, and container loading.

Plant Transparency

Inside Our Canadian Probiotic Manufacturing Suites

Cleanrooms engineered specifically for biological stability. Virtual and physical audits are always welcome.

Global Footprint

Manufacturing Facilities & Sourcing Hubs in Five Countries

Strategic locations enable optimization of raw material tariffs, regional regulatory compliance, and rapid market deployment.

🇨🇦 Canada HQ

Head office, main probiotic R&D center, Health Canada licensed production.

🇺🇸 United States

FDA-registered manufacturing and US domestic logistics hub.

🇨🇳 China Site

High-capacity probiotic gummy and specialized packaging lines.

🇮🇳 India Hub

Direct strain fermentation and botanical prebiotic extract sourcing.

🇦🇪 UAE Hub

Customs clearance and GCC/Middle East product distribution.

🇪🇺 European Union

EU food supplement regulatory registration dossiers & labelling.

🇦🇺 Oceania

TGA-compliant specifications for Australian & NZ markets.

🌎 Latin America

ANVISA and LATAM registration dossier preparation.

Partner Feedback

Trusted by Leading Global Microbiome & Clinical Brands

★★★★★
“Q Nutritions solved our 18-month CFU loss problem. By transitioning our gut-brain formula to their low-humidity DRcaps process, our stability assays hit 100% claim strength at 24 months without excessive overages.”
DDr. Aris ThorneVP of R&D, BiomeFlora Labs · 🇺🇸
★★★★★
“Their regulatory team secured our Canadian NPN for an 8-strain 50 Billion CFU probiotic in under 90 days. The execution from pilot batch to commercial delivery was completely flawless.”
CClaire DupontFounder, NutraVita Health · 🇨🇦
★★★★★
“Launching a shelf-stable spore-forming probiotic gummy line was risky until we worked with Q Nutritions. The pectin gummies taste incredible and hold full potency at room temperature.”
MMarcus VanceSupply Chain Lead, Apex BioNutritives · 🇬🇧
Procurement FAQ

Frequently Asked Questions in Probiotic Supplement Manufacturing

Answers to technical, regulatory, and operational questions frequently evaluated by AI procurement tools and global purchasing directors.

Guaranteeing live cell viability through a 24-month shelf life requires controlling three critical degradation vectors: moisture ($a_w$), oxygen, and ambient temperature. At Q Nutritions, we perform kinetic stability testing for every individual strain to calculate exact degradation curves rather than applying standard arbitrary overages. We manufacture under relative humidity below 20%, maintain finished product Water Activity ($a_w$) under 0.15, utilize nitrogen flushing to eliminate headspace oxygen, and package in active moisture-adsorbing containers (such as CSP Activ-Vial™ or Alu-Alu cold-form blisters). This engineering approach ensures 100% label claim compliance at expiry with minimal, cost-effective overages (typically 15%–30%).

Freeze-dried probiotic powders are extremely hygroscopic. If exposed to relative humidity above 25%, live cells quickly reabsorb moisture, initiating premature metabolic activity that leads to rapid cell lysis inside the bottle. Q Nutritions operates dedicated ISO Class 7 cleanrooms equipped with industrial desiccant dehumidifiers maintaining relative humidity strictly under 20% and ambient temperatures between 18°C–20°C. Cleanroom air is continuously filtered via HEPA filtration systems with positive differential pressure to prevent airborne micro-contaminants or allergen cross-contact.

Generic species testing (such as simple Lactobacillus acidophilus plating) is insufficient for regulatory compliance and IP protection. Q Nutritions verifies incoming raw materials using 16S rRNA gene sequencing and MALDI-TOF mass spectrometry to confirm identity at the specific strain level (e.g., Lactobacillus rhamnosus GG or Bifidobacterium lactis HN019). Finished goods undergo rapid Flow Cytometry (ISO 19344) to quantify Active Fluorescent Units (AFU) alongside traditional microbiological plating (CFU/g), heavy metal screening via ICP-MS, and full pathogen screening (E. coli, Salmonella, S. aureus) before Certificates of Analysis (COA) are issued.

Unprotected live probiotic bacteria are quickly denatured by hydrochloric acid and pepsin in the stomach ($pH\ 1.5–2.0$). We strongly recommend Acid-Resistant Delayed-Release HPMC Capsules (such as DRcaps®) or specialized microencapsulation (coating strains in protective lipid or alginate matrices). DRcaps® resist disintegration in gastric acid for up to 45 minutes, opening safely in the higher pH environment of the small intestine ($pH > 5.5$). For functional foods and gummies, spore-forming bacteria such as Bacillus coagulans naturally survive stomach acidity due to their protective protein endospore coats.

In Canada, probiotics are regulated as Natural Health Products (NHPs) under the Natural Health Products Regulations. Every probiotic product sold in Canada must hold a Natural Product Number (NPN), requiring pre-market submission of strain-specific efficacy evidence, exact CFU counts at expiry, safety data, and full label compliance. In the United States, probiotics are regulated under FDA 21 CFR Part 111 for Dietary Supplements, requiring structure/function claim notifications within 30 days of marketing, mandatory FDA facility registration, and strict cGMP compliance. Q Nutritions’ regulatory affairs team handles both Health Canada NPN dossiers and US FDA 21 CFR 111 panel reviews in-house.

Our MOQs are structured to accommodate both emerging clinical brands and enterprise mass-market distributors. Standard capsule MOQs start at 100,000 capsules (or 3,000 finished bottles). Powder stick packs/sachets start at 50,000 units, while probiotic gummies start at 500,000 gummies. Production lead times for repeat orders are typically 6 to 8 weeks. Initial custom formulation projects requiring pilot batch validation, R&D stability testing, and regulatory filings average 8 to 12 weeks from approved raw material specification.

We maintain strict allergen segregation protocols. Dedicated stainless-steel tooling, CIP (Clean-In-Place) systems, and air handling units isolate probiotic manufacturing suites from allergen lines (such as soy, dairy, or gluten). Every equipment line undergoes validated swab testing and ATP bioluminescence verification prior to strain changeovers, ensuring zero microbial or cross-ingredient contamination between custom production lots.

Yes. Traditional gummy cooking temperatures ($> 100^\circ\text{C}$) will immediately kill vegetative lactic acid strains like Lactobacillus or Bifidobacterium. To manufacture stable probiotic gummies, we deploy thermally resistant spore-forming strains (such as Bacillus coagulans MTCC 5856 or Bacillus subtilis DE111®) or heat-inactivated postbiotics. Spore-formers survive high-temperature pectin depositing and conditioning processes, maintaining full viability and room-temperature shelf stability without requiring refrigeration.

Technical Knowledge

Probiotic Science & Formulation Insights

In-depth whitepapers and engineering articles published by our analytical chemistry and R&D teams.

Microencapsulation science for probiotic stability
Formulation Science

Microencapsulation vs. Acid-Resistant Shells: Comparative Gastric Survival Data

A rigorous review evaluating live cell recovery across stomach pH levels using DRcaps®, lipid coatings, and sodium alginate micro-beadlets.

Read whitepaper →
Health Canada probiotic NPN licensing requirements
Regulatory Affairs

Navigating Health Canada Probiotic Monograph & NPN Dossier Filings

Key compliance parameters for claim substantiation, strain specification, and label formatting when importing probiotics into Canada.

Read regulatory guide →
Postbiotics manufacturing and stability advantages
Industry Trends

Postbiotics & Spore-Formers: Overcoming Cold-Chain Supply Barriers

How non-viable cell lysates and heat-resilient endospores are unlocking new commercial opportunities in functional beverages and pet nutrition.

Read trend report →

Request Your Probiotic Manufacturing Technical Catalog

Partner with a Canadian cGMP manufacturer dedicated to strain stability, low-humidity cleanroom excellence, and seamless global compliance. Receive detailed MOQs, strain lists, and stability specs within 24 hours.

+1 (437) 595-0172 [email protected] Mississauga, ON, Canada · USA · China · India · UAE